Bio Green Med Highlights 2025 Transition and Improved Results

The latest update is out from Bio Green Med Solution ( (BGMS) ).

Bio Green Med Solution, Inc., now focused on fire safety protection and distribution after exiting its legacy biopharmaceutical activities, reported that the September 12, 2025 acquisition of Fitters Sdn. Bhd. generated $0.7 million in fire safety product revenue for both the fourth quarter and full year 2025. The company’s transition included liquidating its U.K. subsidiary and divesting oncology asset plogosertib, moves aimed at strengthening the balance sheet and consolidating its new operating profile in Malaysia.

For the year ended December 31, 2025, BGMS reduced its net loss to $3.0 million from $11.2 million in 2024, helped by a sharp decline in R&D spending to $0.8 million after winding down drug programs and by $5.4 million in other income tied mainly to the deconsolidation of Cyclacel Limited and the plogosertib sale. Cash and cash equivalents stood at $3.5 million versus $3.8 million a year earlier, with management indicating that existing resources should cover planned expenditures into the third quarter of 2026, while higher general and administrative costs reflected one-time expenses from two changes of control during 2025.

The most recent analyst rating on (BGMS) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Bio Green Med Solution stock, see the BGMS Stock Forecast page.

Spark’s Take on BGMS Stock

According to Spark, TipRanks’ AI Analyst, BGMS is a Neutral.

The score is primarily constrained by weak financial performance: very small revenue, deeply negative margins, and substantial ongoing cash burn despite an improved, low-debt balance sheet. Technicals also remain unfavorable with price below key moving averages and negative MACD. Valuation is mixed—an unusually high dividend yield provides some support, but the negative P/E underscores continued losses.

To see Spark’s full report on BGMS stock, click here.

More about Bio Green Med Solution

Bio Green Med Solution, Inc., formerly Cyclacel Pharmaceuticals, Inc., is a Malaysia-headquartered diversified company that shifted in September 2025 from biopharmaceuticals to the provision and distribution of fire safety protection products and services. The strategic pivot was anchored by the September 12, 2025 acquisition of Malaysia-based Fitters Sdn. Bhd., positioning BGMS in the regional fire protection market and refocusing its operations on this sector.

Average Trading Volume: 88,166

Technical Sentiment Signal: Strong Sell

Current Market Cap: $4.9M

For detailed information about BGMS stock, go to TipRanks’ Stock Analysis page.